We accomplished this aim by using label-free mass spectrometry and bioinformatic analyses to study changes in serum proteomes associated with CBS deficiency and ischemic stroke subtypes and to identify molecular pathways and networks involved. This evidence concerns the gene CBS and ischemic stroke.